137
Views
6
CrossRef citations to date
0
Altmetric
Original

Belara® – proven benefits in daily practice

Pages 19-25 | Published online: 06 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

J. Spona, N. Binder, K. Höschen & W. Feichtinger. (2008) Contraceptive efficacy and safety of a low-dose oral contraceptive, (0.03 mg ethinyl oestradiol and 2 mg chlormadinone acetate) Belara®, over three medication cycles. The European Journal of Contraception & Reproductive Health Care 13:1, pages 39-48.
Read now

Articles from other publishers (5)

V. Vautier. (2018) Comment prescrire une contraception orale chez l’adolescente ?. Perfectionnement en Pédiatrie 1:3, pages 176-184.
Crossref
L. V. Erofeeva. (2017) COMBINED HORMONAL CONTRACEPTION AND NOT ONLY…. Medical Council:2, pages 38-44.
Crossref
Thomas Rabe, Elena Hartschuh, Torsten Wahlstrom, Kornelia Höschen & Simone König. (2010) Endometrial safety of a novel monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen over six cycles. Contraception 82:4, pages 358-365.
Crossref
Jürgen Spona, Natascha Binder, Kornelia Höschen & Wilfried Feichtinger. (2010) Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl estradiol and 2 mg chlormadinone acetate given in a 24/4-day intake regimen over three cycles. Fertility and Sterility 94:4, pages 1195-1201.
Crossref
G. Robin, P. Massart & B. Letombe. (2007) La contraception des adolescentes en France en 2007. Gynécologie Obstétrique & Fertilité 35:10, pages 951-967.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.